Zenith Healthcare Reports FY26 Net Profit of ₹0.0051 Crore, Posts Quarterly Loss

Zenith Healthcare Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a net profit of ₹0.0051 crore for the full fiscal year, a significant drop from ₹0.067 crore in the previous year. For the fourth quarter, Zenith Healthcare registered a net loss of ₹0.342 crore.

Reader Takeaway: Profitability decline and negative cash flow are key concerns, while a new Joint MD brings leadership changes.

What just happened

Zenith Healthcare Limited announced its audited financial results for the fiscal year and quarter ending March 31, 2026. The company posted a net profit of ₹0.0051 crore for the full year, down from ₹0.067 crore in FY25. The fourth quarter saw a net loss of ₹0.342 crore, compared to a profit of ₹0.1097 crore in the same period last year.

Revenue from operations for the full year stood at ₹10.52 crore, a slight decrease from ₹11.33 crore in FY25. Quarterly revenue also saw a sharp fall to ₹2.62 crore from ₹0.345 crore in the previous year's quarter.

Additionally, Mr. Akshit Mahendra Raycha has been appointed as the Joint Managing Director for three years, effective May 29, 2026, with a monthly remuneration of up to ₹2,00,000. M/s. Mohta Khetawat & Co. has been appointed as the internal auditor for FY27.

Why this matters

The sharp decline in profitability, especially the shift to a quarterly loss and the near-zero annual profit, indicates significant financial challenges. The negative operating cash flow of ₹-0.834 crore for the year raises concerns about the company's liquidity and working capital management. These financial pressures could impact future operations and growth.

The appointment of a Joint Managing Director suggests a move to strengthen leadership. Investors will be watching how the new leadership navigates these financial difficulties and drives future strategy.

The backstory

In the previous fiscal year (FY25), Zenith Healthcare had reported a net profit of ₹0.067 crore and positive operating cash flow. However, the current results show a marked deterioration in financial performance, with revenues declining and profitability shrinking to negligible levels, culminating in a quarterly loss.

What changes now

The company's leadership structure has been enhanced with the appointment of a Joint Managing Director. This new role is expected to bring fresh perspectives and drive strategic initiatives. However, the immediate focus will likely be on addressing the profitability and cash flow concerns.

Risks to watch

• Profitability: The company faces a significant risk of sustained losses if operational challenges are not addressed. The annual profit has dwindled to almost zero.
• Liquidity: Negative operating cash flow is a critical concern. A continued strain on cash flow could impact the company's ability to meet its short-term obligations.
• Revenue Decline: The year-on-year decrease in revenue suggests potential market challenges or issues with sales execution.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

• Net Profit FY26: ₹0.0051 crore (vs. ₹0.067 crore in FY25)
• Net Loss Q4 FY26: ₹-0.342 crore (vs. ₹0.1097 crore profit in Q4 FY25)
• Revenue FY26: ₹10.52 crore (vs. ₹11.33 crore in FY25)
• Operating Cash Flow FY26: ₹-0.834 crore (vs. ₹0.5544 crore in FY25)

What to track next

Investors should closely monitor the company's subsequent financial results, focusing on trends in revenue, profitability, and cash flow. Any strategic initiatives announced by the new Joint Managing Director and their impact on operational performance will be crucial to track.